NASDAQ: NUWE

Delivering Innovative Fluid Management Solutions to Improve Patient Outcomes

SEC Filings, Corporate Governance, Shareholder Resources

About Nuwellis

Nuwellis, Inc. (Nasdaq: NUWE) is a medical technology company delivering innovative fluid-balance technologies for patients with acute & chronic cardiorenal conditions.

The Aquadex SmartFlow® system provides clinicians with a safe, flexible, and efficient method of removing excess fluid in patients suffering from heart failure, critical care challenges, and pediatric conditions.

Nuwellis Investor Presentation

Unlocking a New Standard in Cardiorenal Care

Download Presentation

Events

  • Events
  • Previous Events
Events Previous Events
DateTitlePDF Download
August 13, 2026 Webcast: Nuwellis, Inc Second Quarter 2026 Earnings Read More View
May 12, 2026 Webcast: Nuwellis, Inc First Quarter 2026 Earnings Read More View
March 10, 2026 Webcast: Nuwellis Inc Fourth Quarter 2025 Earnings Read More
DateTitlePDF Download
March 10, 2026 Webcast: Nuwellis, Inc Fourth Quarter 2025 Earnings Read More
November 12, 2025 Webcast: Nuwellis, Inc Third Quarter 2025 Earnings Read More
August 21, 2025 Webcast: Webull Financial Corporate Connect Webinar Series: Biotech/MedTech Read More
August 14, 2025 Webcast: Nuwellis, Inc Second Quarter 2025 Earnings Read More
May 13, 2025 Webcast: Nuwellis, Inc First Quarter 2025 Earnings Read More
March 11, 2025 Webcast: Nuwellis, Inc Fourth Quarter 2024 Earnings Read More
October 20, 2021 American College of Chest Physicians (CHEST) Annual Meeting Read More
September 11, 2021 Heart Failure Society of America (HFSA) Annual Scientific Meeting Read More
July 11, 2021 Florida Society of Thoracic & Cardiovascular Surgeons Annual Scientific Meeting Read More

Nuwellis Corporate Governance

Board Committees & Charters

Nuwellis’s Board of Directors sets high standards for employees, officers and directors. Implicit in this philosophy is the importance of sound corporate governance. To fulfill its responsibilities and to discharge its duty, the Board of Directors follows the procedures and standards that are in the following guidelines. These guidelines are subject to modification from time to time as the Board of Directors deems appropriate in the best interests of the Company or as required by applicable laws and regulations.

Audit Committee

Greg Waller (Chair)
Marty Emerson
Dave McDonald

Compensation Committee

Archelle Georgiou, MD (Chair)
Greg Waller
Marty Emerson

Nominating & Corporate Governance Committee

Archelle Georgiou, MD (Chair)
Marty Emerson
Dave McDonald

View All Leadership

Governance Policies

Corporate Governance Guidelines
View
Code of Business Conduct and Ethics
View
Audit Committee Charter
View
Compensation Committee Charter
View
Policy for the Recovery of Erroneously Awarded Compensation
View
Nominating and Corporate Governance Committee Charter
View
Insider Trading Policy

View

Contact Investor Relations

Nuwellis, Inc.
12988 Valley View Road
Eden Prairie, MN 55344

Email Us Call Us

Risk Factors & Compliance

Operating in the medical device industry involves certain risks and regulatory obligations. Key risks include:

  • Market adoption of our technologies
  • Regulatory approvals and compliance with FDA and international standards
  • Reimbursement policies in healthcare systems
  • Competition and technological innovation
  • Risks outlined in our most recent Form 10-K and Form 10-Q

Investors should review our SEC filings for a full discussion of risk factors.

Forward-Looking Statements

Certain statements on this page are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve risks and uncertainties that may cause actual results to differ materially. Please refer to our most recent SEC filings for a discussion of risk factors.